Skip to content

Simeprevir with interferon effective for HIV/HCV co-infected people with genotype 1 hepatitis C

Douglas Dieterich at EACS 2013. Photo by Liz Highleyman, hivandhepatitis.com

New drugs will bring revolution in hepatitis C treatment

Heiner Wedemeyer, Hannover Medical School, at EACS 2013. Photo by Liz Highleyman, hivandhepatitis.com

Predicting response to acute hepatitis C treatment in HIV/HCV co-infected people

Daclatasvir works well against hepatitis C either with interferon or in all-oral regimen

People with HIV/HCV-co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease

AbbVie interferon-free hepatitis C combo works well with reduced ribavirin dose

The beginning of the end of hepatitis C?

New HCV combinations could have a big role in prevention, but only if treatment rates increase

Daclatasvir + asunaprevir + BMS-791352 looks promising as interferon-free combination